Safety and activity of the first-in-class Sym004 anti-EGFR antibody mixture in patients with refractory colorectal cancer

  1. Dienstmann, R.
  2. Patnaik, A.
  3. Garcia-Carbonero, R.
  4. Cervantes, A.
  5. Benavent, M.
  6. Roselló, S.
  7. Tops, B.B.
  8. van der Post, R.S.
  9. Argilés, G.
  10. Skartved, N.J.Ø.
  11. Hansen, U.H.
  12. Hald, R.
  13. Pedersen, M.W.
  14. Kragh, M.
  15. Horak, I.D.
  16. Braun, S.
  17. Van Cutsem, E.
  18. Tolcher, A.W.
  19. Tabernero, J.
Journal:
Cancer Discovery

ISSN: 2159-8290 2159-8274

Year of publication: 2015

Volume: 5

Issue: 6

Pages: 598-609

Type: Article

DOI: 10.1158/2159-8290.CD-14-1432 GOOGLE SCHOLAR lock_openOpen access editor